Category: Finance
-
Start-Up Creating Digital Therapies for Alzheimer’s
A new enterprise is developing personalized digital therapeutics for people with Alzheimer’s disease and other neurodegenerative disorders.
-
Biotech Creating More Efficient Crispr Therapies
A biotechnology company is developing treatments for cancer and other diseases using Crispr gene editing delivered with more efficient synthetic proteins.
-
Therapist-Guided Home Stroke Rehab System in Works
A university lab is designing a system that allows for people with stroke to perform rehabilitation at home, while still guided remotely by a therapist.
-
Lightweight AI Chip Designer Raises $2.8M in Seed Funds
A new company is designing computer chips and devices with artificial intelligence modeled on insect brains for autonomous vehicles and robotic systems.
-
Natural-Killer Cell Cancer Therapy Biotech Launches
A new company is underway creating off-the-shelf engineered cells from the immune system as cancer treatments, and raising $42 million in venture funds.
-
Infographic – Vaccines Boost Biotech Shares
News of those trials fueled healthy share price rises for the biotechnology companies developing the vaccines, shown in this weekend’s infographic.
-
Cancer Immune System Therapy Start-Up Raises $53M
A company developing treatments that retune the immune system to kill solid tumor and blood-related cancers is raising $53 million in its first venture funding.
-
$500K Challenge Seeks A.I. Covid-19 Reopening Models
A new challenge from XPrize seeks evidence-based models using artificial intelligence to help governments reopen their economies during the pandemic.
-
Gene-Editing Enzyme Start-Up Gains $65M
A new company creating engineered enzymes for genome editing therapeutics is raising $65 million in its first venture funding round.
-
Coronavirus Antibody Maker Raises $80M in New Funds
A company developing synthetic antibodies to protect against a range of coronavirus infections, including Covid-19, is raising $80 million in new venture funds.